Greenleaf Trust Cuts Position in Stericycle Inc. (SRCL)
Greenleaf Trust cut its stake in Stericycle Inc. (NASDAQ:SRCL) by 21.8% during the second quarter, Holdings Channel reports. The institutional investor owned 4,463 shares of the company’s stock after selling 1,243 shares during the period. Greenleaf Trust’s holdings in Stericycle were worth $465,000 as of its most recent filing with the SEC.
A number of other large investors have also modified their holdings of SRCL. Balentine LLC increased its stake in shares of Stericycle by 34.9% in the first quarter. Balentine LLC now owns 1,064 shares of the company’s stock valued at $134,000 after buying an additional 275 shares in the last quarter. Canada Pension Plan Investment Board boosted its position in shares of Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock valued at $179,000 after buying an additional 497 shares during the last quarter. Meeder Asset Management Inc. purchased a new position in shares of Stericycle during the second quarter valued at about $155,000. Jones Financial Companies Lllp purchased a new position in shares of Stericycle during the first quarter valued at about $203,000. Finally, Trust Co. of Vermont boosted its position in shares of Stericycle by 70.9% in the second quarter. Trust Co. of Vermont now owns 1,784 shares of the company’s stock valued at $186,000 after buying an additional 740 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.
Shares of Stericycle Inc. (NASDAQ:SRCL) traded down 0.04% during mid-day trading on Thursday, hitting $76.55. The stock had a trading volume of 1,640,437 shares. Stericycle Inc. has a 52-week low of $75.31 and a 52-week high of $151.57. The company has a market cap of $6.51 billion, a PE ratio of 26.94 and a beta of 0.20. The stock has a 50 day moving average price of $82.10 and a 200-day moving average price of $99.74.
Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.18. The firm earned $891.60 million during the quarter, compared to analysts’ expectations of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The business’s revenue was up 24.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.14 EPS. On average, equities analysts expect that Stericycle Inc. will post $4.67 earnings per share for the current fiscal year.
Several research analysts have recently issued reports on the company. Zacks Investment Research cut Stericycle from a “buy” rating to a “hold” rating in a research note on Thursday, July 14th. Wedbush reduced their price objective on Stericycle from $95.00 to $85.00 and set a “neutral” rating for the company in a research note on Thursday, September 22nd. Robert W. Baird reduced their price objective on Stericycle from $99.00 to $85.00 and set a “neutral” rating for the company in a research note on Friday, September 23rd. Northcoast Research cut Stericycle from a “buy” rating to a “neutral” rating in a research note on Tuesday, September 20th. Finally, Jefferies Group restated a “buy” rating and issued a $125.00 price objective (down from $140.00) on shares of Stericycle in a research note on Friday, July 29th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the stock. Stericycle has an average rating of “Hold” and a consensus price target of $103.54.
In other Stericycle news, Director Mark C. Miller sold 34,835 shares of the stock in a transaction that occurred on Friday, July 8th. The stock was sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the completion of the sale, the director now directly owns 244,284 shares of the company’s stock, valued at approximately $25,532,563.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of the stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the sale, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at $89,052.80. The disclosure for this sale can be found here. Company insiders own 3.30% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.